IL‐6 signaling regulates the inflammatory response without impacting pathogen burden during influenza‐associated pulmonary aspergillosis

IL‐6 signaling regulates the inflammatory response without impacting pathogen burden during influenza‐associated pulmonary aspergillosis

Abstract Viral infections increase host susceptibility to opportunistic pathogens like Aspergillus fumigatus (AF), exacerbating disease severity and prolonging its clinical course. Interleukin‐6 (IL‐6) drives pathological inflammation in viral infections such as COVID‐19, but its role in influenza,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lokesh Sharma, Ravineel B. Singh, Nathaniel J. Tolman, Caden Ngeow, Alexis M. Duray, Nima Naghshtabrizi, Aijaz Ahmad, William Bain, Keven M. Robinson
Format:	Article
Language:	English
Published:	Wiley 2025-05-01
Series:	Physiological Reports
Subjects:	aspergillus IL‐6 signaling inflammation influenza influenza associated pulmonary aspergillosis
Online Access:	https://doi.org/10.14814/phy2.70372
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Restoration of Type 17 immune signaling is not sufficient for protection during influenza-associated pulmonary aspergillosis
by: Aijaz Ahmad, et al.
Published: (2025-01-01)

Invasive pulmonary aspergillosisas a complication of severe influenza (case report)
by: Yu. E. Melekhina, et al.
Published: (2020-03-01)

Immunotherapy with nebulized pattern recognition receptor agonists restores severe immune paralysis and improves outcomes in mice with influenza-associated pulmonary aspergillosis
by: Jezreel Pantaleón García, et al.
Published: (2025-05-01)

Therapeutic JAK inhibition does not impact lung injury during viral or bacterial pneumonia in male mice
by: Lokesh Sharma, et al.
Published: (2025-02-01)

Pulmonary aspergillosis in patients with asthma
by: Mihailo Stjepanovic, et al.
Published: (2025-06-01)

Pulmonary Aspergillosis in Patients with Cystic Fibrosis in Russian Federation
by: Ya. I. Kozlova, et al.
Published: (2018-07-01)

Invasive aspergillosis a complication severe respiratory viral infections (influenza and COVID-19)
by: N. N. Klimko, et al.
Published: (2021-12-01)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

Primary renal aspergillosis in a newborn: a case report and review of the literature on children
by: Julio Maquera-Afaray, et al.
Published: (2022-06-01)

COVID-19 Associated Pulmonary Aspergillosis: A Case Series
by: Mira Yulianti, et al.
Published: (2022-07-01)

Invasive aspergillosis in adult patients with rheumatic diseases
by: V. I. Mazurov, et al.
Published: (2020-11-01)

Invasive pulmonary aspergillosis in COVID-19 patients
by: V. G. Gusarov, et al.
Published: (2021-03-01)

INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-07-01)

Multilocus Sequence Analysis of Aspergillus Species from Clinical Samples and the Surge of Cryptic Aspergillosis in Southern India: A Descriptive Cross-sectional Study
by: Almas Fathima Upaisal, et al.
Published: (2024-10-01)

An asthmatic child with allergic bronchopulmonary aspergillosis (ABPA)
by: Öner Özdemir
Published: (2018-08-01)

Outcome Analysis of Breakthrough Invasive Aspergillosis on Anti-Mold Azole Prophylaxis and Treatment: 30-Year Experience in Hematologic Malignancy Patients
by: Hiba Dagher, et al.
Published: (2025-02-01)

Invasive pulmonary aspergillosis: the state of art and the clinical case.
by: K. Yu. Gashynova, et al.
Published: (2018-04-01)

Implications for the diagnosis of aspiration and aspergillosis in critically ill patients with detection of galactomannan in broncho-alveolar lavage fluids
by: Simon Dubler, et al.
Published: (2025-01-01)

PANoptosis opens new treatment options for allergic bronchopulmonary aspergillosis
by: Dalan Smallwood, MD, et al.
Published: (2024-11-01)

COMBINATION OF INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-02-01)

Navigating Diagnostic Challenges in Pulmonary Aspergillosis: A Case Series Demonstrating the Synergy of Investigation Techniques
by: Anooja Pulimoottil Mani, et al.
Published: (2025-06-01)

Enhanced influenza vaccination among healthcare personnel prevents cases despite community burden
by: Isaí Medina-Piñón, et al.
Published: (2019-02-01)

Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria
by: O. J. Balogun, et al.
Published: (2025-03-01)

Historic Influenza Perspectives on an Influenza Pandemic
by: Des Martins
Published: (2003-04-01)

SAFETY ASSESSMENT OF TWO SUBUNIT INFLUENZA VACCINES IN CHILDREN WITH A BURDENED ALLERGOANAMNEZ
by: M. G. Galitskaya, et al.
Published: (2015-08-01)

First Description of Atypical Aspergillus floccosus as Cause of Canine Systemic Aspergillosis With Discospondylitis
by: Talita Bordoni, et al.
Published: (2025-07-01)

Cytological Evaluation of Pulmonary Aspergillosis in Patients Living with HIV/AIDS in Kano, Nigeria
by: Yusuf, H.Z.1, et al.
Published: (2021-03-01)

Enhanced Influenza Surveillance Utilizing Rapid Diagnostic Tests in the Emergency Department
by: Janice Caoili, et al.
Published: (2024-12-01)

Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012–2018
by: Lise Bertin-Biasutto, et al.
Published: (2025-05-01)

Allergic Bronchopulmonary Aspergillosis Misdiagnosed as Non-resolving Pneumonia: A Case Report
by: Reem Alsowayan
Published: (2025-07-01)

Safety and Influenza Infections in Children Aged 6–35 Months Receiving Cell Culture-Derived Inactivated Quadrivalent Influenza Vaccine During the 2023–2024 Influenza Season in South Korea
by: Hye Eun Lee, et al.
Published: (2025-05-01)

Invasive aspergillosis caused by <i>Aspergillus non-fumigatus</i> after allogeneic hematopoietic stem cell transplantation
by: V. V. Markelov, et al.
Published: (2023-01-01)

Epidemiological, serological, and genetic evidence of influenza D virus infection in humans: Is it a justifiable cause for concern?
by: Widaliz Vega-Rodriguez, et al.
Published: (2023-12-01)

Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
by: Paulami Chatterjee, et al.
Published: (2024-09-01)

A preliminary exploration of influenza-like illness surveillance and influenza vaccination in Jing’an District of Shanghai， 2017‒2023
by: HUA Ruijue, et al.
Published: (2025-04-01)

Evaluation of a novel Aspergillus IgG lateral flow assay for the diagnosis of non-neutropenic patients with acute and subacute invasive aspergillosis
by: Yajie Lu, et al.
Published: (2025-06-01)

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review
by: Yan Chen, et al.
Published: (2025-01-01)

Isavuconazole and Amphotericin B Synergic Antifungal Activity: In Vitro Evaluation on Pulmonary Aspergillosis Molds Isolates
by: Maddalena Calvo, et al.
Published: (2024-10-01)

Correction: Evaluation of a novel Aspergillus IgG lateral flow assay for the diagnosis of non-neutropenic patients with acute and subacute invasive aspergillosis
by: Yajie Lu, et al.
Published: (2025-07-01)

Investigation of influenza and respiratory viruses in hospitalised patients with influenza-like illness in an emergency room
by: Pinar Aysert-Yildiz, et al.
Published: (2019-11-01)